These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660 [TBL] [Abstract][Full Text] [Related]
3. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Douketis JD; Foster GA; Crowther MA; Prins MH; Ginsberg JS Arch Intern Med; 2000 Dec 11-25; 160(22):3431-6. PubMed ID: 11112236 [TBL] [Abstract][Full Text] [Related]
4. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism. Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588 [TBL] [Abstract][Full Text] [Related]
5. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L, Ninet J, Duhaut P et al for the Investigators of the 'Durée Optimale du Traitement Antivitamines K' (DOTAVK) study. Circulation 2001; 103: 2453-60. Anand SS Vasc Med; 2001 Nov; 6(4):269-70. PubMed ID: 11958396 [TBL] [Abstract][Full Text] [Related]
6. Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta-analysis of randomized controlled trials. Mearns ES; Coleman CI; Patel D; Saulsberry WJ; Corman A; Li D; Hernandez AV; Kohn CG J Thromb Haemost; 2015 Jun; 13(6):1043-52. PubMed ID: 25819920 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L; Ninet J; Duhaut P; Chabaud S; Demolombe-Rague S; Durieu I; Nony P; Sanson C; Boissel JP; Circulation; 2001 May; 103(20):2453-60. PubMed ID: 11369685 [TBL] [Abstract][Full Text] [Related]
8. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study. Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701 [TBL] [Abstract][Full Text] [Related]
9. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism. Farge D; Trujillo-Santos J; Debourdeau P; Bura-Riviere A; Rodriguez-Beltrán EM; Nieto JA; Peris ML; Zeltser D; Mazzolai L; Hij A; Monreal M; Medicine (Baltimore); 2015 Aug; 94(32):e1235. PubMed ID: 26266353 [TBL] [Abstract][Full Text] [Related]
10. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review. Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis. Di Minno MN; Ambrosino P; Ambrosini F; Tremoli E; Di Minno G; Dentali F J Thromb Haemost; 2016 May; 14(5):964-72. PubMed ID: 26845754 [TBL] [Abstract][Full Text] [Related]
12. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study. Barco S; Pomero F; Di Minno MND; Tamborini Permunian E; Malato A; Pasca S; Barillari G; Fenoglio L; Siragusa S; Di Minno G; Ageno W; Dentali F J Thromb Haemost; 2017 Nov; 15(11):2176-2183. PubMed ID: 28871623 [TBL] [Abstract][Full Text] [Related]
13. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis. Marik PE; Cavallazzi R PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983 [TBL] [Abstract][Full Text] [Related]
14. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569 [TBL] [Abstract][Full Text] [Related]
16. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis. Mismetti P; Quenet S; Levine M; Merli G; Decousus H; Derobert E; Laporte S Chest; 2005 Oct; 128(4):2203-10. PubMed ID: 16236875 [TBL] [Abstract][Full Text] [Related]
17. Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study. Schellong S; Ageno W; Casella IB; Chee KH; Schulman S; Singer DE; Desch M; Tang W; Voccia I; Zint K; Goldhaber SZ Semin Thromb Hemost; 2022 Jun; 48(4):446-458. PubMed ID: 33971682 [TBL] [Abstract][Full Text] [Related]